Search Results

Your search for Thomas E. Witzig, MD matches 2 pages

Showing 1 - 2

By Matthew Stenger / February 2021

Effect of Organ Function–Based Eligibility Criteria on Clinical Trial Enrollment for Patients With DLBCL

In a study reported in the Journal of Clinical Oncology, Khurana et al found that up to 24% of patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) receiving standard immunochemotherapy are excluded from participation in clinical trials on the basis of organ function eligibility...

issues in oncology

By Thomas E. Witzig, MD / February 10, 2019

Essential Elements of an Effective Clinical Trials System: Business and Mission

Clinical trials aimed to improve health and quality of life are the cornerstone of progress in medicine. Support comes from academic medical centers, philanthropy, the National Institutes of Health (NIH), industry, or combinations thereof. Clinical trials need to be hypothesis-driven and address...

Apr

Today In Oncology

Search Results

Your search for Thomas E. Witzig, MD matches 2 pages

Effect of Organ Function–Based Eligibility Criteria on Clinical Trial Enrollment for Patients With DLBCL

Essential Elements of an Effective Clinical Trials System: Business and Mission

Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being